Molecular Templates Inc. [MTEM] shares are up more than 13.30% this year and recently decreased -0.03% or -$0.3 to settle at $9.07. MTEM has a short ratio of 4.93. This implies that the market is currently less bearish on the outlook for MTEM.

On 18, November 2020, SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. – MTEM. According to news published on Yahoo Finance, NEW YORK, NY / ACCESSWIRE / November 18, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Molecular Templates, Inc. (“Molecular” or the “Company”) (NASDAQ:MTEM). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 7980.

Analyst Birdseye View:

The most recent analyst activity for Molecular Templates Inc. [NASDAQ:MTEM] stock was on March 25, 2020, when it was Initiated with a Buy rating from Stifel, which also raised its 12-month price target on the stock to $19. Before that, on September 08, 2020, Jefferies Recapitulated a Buy rating and elevated its amount target to $21. On February 27, 2020, Barclays Initiated an Overweight rating and boosted its price target on this stock to $22. On April 29, 2019, UBS Initiated a Buy rating and increased its price target to $12. On December 11, 2018, Oppenheimer Initiated an Outperform rating and increased its price target to $15. On October 08, 2018, Laidlaw Initiated a Buy rating and boosted its amount on this stock to $18.

In the past 52 weeks of trading, this stock has oscillated between a low of $7.51 and a peak of $19.12. At the most recent market close, shares of Molecular Templates Inc. [NASDAQ:MTEM] were valued at $9.07.


Molecular Templates Inc. [NASDAQ:MTEM] most recently reported quarterly sales of 4.3 billion, which represented growth of 19.40%. This publicly-traded organization’s revenue is $132,560 per employee, while its income is -$413,220 per employee. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -44.17, -68.08, -43.24 and -62.59 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 13.68 and the whole liability to whole assets at 9.37. It shows enduring liability to the whole principal at 12.25 and enduring liability to assets at 0.08 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 8.96 points at 1st support level, the second support level is making up to 8.55. But as of 1st resistance point, this stock is sitting at 9.68 and at 9.98 for 2nd resistance point.

Molecular Templates Inc. [MTEM] reported its earnings at -$0.47 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.55/share signifying the difference of 0.08 and 14.50% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.68 calling estimates for -$0.48/share with the difference of -0.2 depicting the surprise of -41.70%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Molecular Templates Inc. [NASDAQ:MTEM] is 3.20. Likewise, the Quick ratio is also the same, showing Cash ratio at 3.49. Now if looking for a valuation of this stock’s amount to sales ratio it’s 23.72 and it’s amount to book ratio is 6.19.

Insider Stories

The most recent insider trade was by BIOTECH TARGET N V, 10% Owner, and it was the purchase of 80000.0 shares on Nov 10. BIOTECH TARGET N V, the 10% Owner, completed a purchase of 80000.0 shares on Nov 09. On Nov 06, BIOTECH TARGET N V, 10% Owner, completed a purchase of 0.47 million shares.